Department of Surgery, Teikyo University Mizonokuchi Hospital, 3-8-3 Mizonokuchi, Takatsu-ku, Kawasaki-shi, Kanagawa, Japan.
Department of Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
Surg Endosc. 2018 Apr;32(4):2157-2158. doi: 10.1007/s00464-017-5829-x. Epub 2017 Sep 15.
The popularity of laparoscopic liver resection (LLR) is spreading, worldwide, because the intraoperative blood loss is less than for open hepatectomy and it is associated with a shorter hospitalization period [1-6]. During LLR, intraoperative hemostasis is difficult to achieve, unlike during laparotomy where bleeding can be stopped instantly [7-10]. Our LLR method for the treatment of hepatocellular carcinoma (HCC) includes maximal control of intraoperative bleeding using a monopolar soft-coagulation device. Although we use a monopolar soft-coagulation device to control bleeding during LLR, while coagulating the thin blood vessels, we also developed a maneuver (the hepatocyte crush method: HeCM) to allow liver transection to progress while liver parenchymal cells are being crushed.
Between January 2008 and March 2016, we performed total LLR on 150 hepatocellular carcinoma patients (144 partial liver resections and six left lateral sectionectomies) using the maneuver shown in the video.
The patients had Child-Pugh Scores of grade A (n = 100), B (42), or C (n = 8) and the localizations of tumor were segment (S) 1(n = 7), S2 (19), S3 (23), S4 (28), S5 (17), S6 (26), S8 (17), and S8 (29). The median blood loss was 30 (range 0-490) g during a median surgical time of 207 (range 127-468) min. One patient required conversion to a laparotomy due to the presence of severe adhesions; none of the patients required conversion due to intraoperative hemorrhage. The peak aspartate aminotransferase (AST) level was 320 (range 57-1964) IU/L. Although some patients showed high AST levels, none showed signs of hepatic failure. The median postoperative hospital stay duration was 6 (range 3-21) days. Postoperative complications occurred in seven cases (4.7%), including intraabdominal abscesses (n = 2), wound infections (2), intraabdominal hemorrhage (1), bile duct stricture (1), and umbilical hernia (1). The mortality was zero.
HeCM, combined with the use of a monopolar soft-coagulation device, is a good technique for reducing bleeding during liver resection in patients with HCC.
腹腔镜肝切除术(LLR)在全球范围内越来越受欢迎,因为与开腹肝切除术相比,术中出血量较少,且住院时间较短[1-6]。在 LLR 过程中,与开腹手术不同,术中止血较难[7-10]。我们治疗肝细胞癌(HCC)的 LLR 方法包括使用单极软凝设备最大限度地控制术中出血。虽然我们在 LLR 过程中使用单极软凝设备来控制出血,同时对细血管进行凝块,但我们还开发了一种操作方法(肝细胞挤压法:HeCM),允许在挤压肝实质细胞的同时进行肝段切除。
2008 年 1 月至 2016 年 3 月,我们使用视频中显示的操作方法对 150 例肝细胞癌患者(144 例部分肝切除术和 6 例左外侧段切除术)进行了完全 LLR。
患者的 Child-Pugh 评分为 A 级(n=100)、B 级(n=42)或 C 级(n=8),肿瘤的定位在 S1(n=7)、S2(19)、S3(23)、S4(28)、S5(17)、S6(26)、S8(17)和 S8(29)。中位出血量为 30(范围 0-490)g,中位手术时间为 207(范围 127-468)min。由于存在严重粘连,1 例患者需要转为剖腹手术;无 1 例患者因术中出血需要转为剖腹手术。天冬氨酸转氨酶(AST)峰值为 320(范围 57-1964)IU/L。尽管一些患者的 AST 水平较高,但均无肝衰竭迹象。中位术后住院时间为 6(范围 3-21)天。7 例患者(4.7%)发生术后并发症,包括腹腔脓肿(n=2)、伤口感染(2)、腹腔内出血(1)、胆管狭窄(1)和脐疝(1)。无死亡病例。
HeCM 联合使用单极软凝设备是减少 HCC 患者肝切除术中出血的良好技术。